GlassScriptPhysician profile
Abdur Khan
NPI 1700132750
$6,929.97
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,618 · 2020: $21.37 · 2021: $127 · 2022: $765 · 2023: $3,172 · 2024: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,718 · Food and Beverage: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,718.36 |
| Food and Beverage | $680.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,505.01 | 2019-2024 | Watchman Access System |
| Siemens Medical Solutions USA, INC. | $1,823.66 | 2022-2024 | Artis Icono Floor, Atellica Im 1300 Analyzer, Somatom X.Cite |
| Bard Peripheral Vascular, INC. | $1,578.00 | 2023 | Venclose Maven Catheter |
| Abbott Laboratories | $193.92 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $159.97 | 2021-2022 | |
| Philips North America LLC | $140.08 | 2022 | |
| Heartflow, INC. | $125.36 | 2022-2024 | |
| Medtronic Vascular, INC. | $58.96 | 2019 | |
| Chiesi USA, INC. | $46.61 | 2023 | Kengreal |
| Novo Nordisk INC | $43.28 | 2024 | Rybelsus, Ozempic |
| Pfizer INC. | $39.41 | 2023 | |
| Cardiovascular Systems INC. | $34.83 | 2020-2021 | |
| Medtronic, INC. | $26.56 | 2022 | |
| W. L. Gore & Associates, INC. | $23.92 | 2023 | Gore Cardioform Septal Occluder |
| Biosense Webster, INC. | $19.48 | 2024 | Qdot Micro Catheter, Carto 3 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.91 | 2021 | |
| Shockwave Medical, INC | $15.80 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.30 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.66 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.99 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $12.80 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.35 | 2019 | |
| Asahi Intecc USA, INC. | $11.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdur Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.